Otologic developing sound solution to hearing loss

Oklahoma City firm developing hearing loss solution.

Imagine if there was a drug that a soldier could swallow immediately after an explosion that would prevent or heal hearing loss.

That’s the potential impact of Otologic Pharmaceutics, Inc. (OPI).

The Oklahoma City firm is working in collaboration with Hough Ear Institute (HEI) and Oklahoma Medical Research Foundation (OMRF) to develop NHPN-1010, a combination of two well-understood and safe compounds, one of which already has FDA approval and the other which comes out of research at OMRF.